Skip Navigation



eCAM Advance Access published online on October 15, 2008
eCAM, doi:10.1093/ecam/nen062
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Upur, H.
Right arrow Articles by Moore, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Upur, H.
Right arrow Articles by Moore, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2008 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine

Halmurat Upur1, Abdiryim Yusup1, Isabelle Baudrimont2, Anwar Umar1, Benedicte Berke1,3, Dilxat Yimit1, Jaya Conser Lapham1, Edmon E. Creppy2 and Nicholas Moore1,4

1Faculty of Traditional Uighur Medicine, Xinjiang Medical University, 830011 Urumqi, China, 2Department of Toxicology, 3Department of Pharmacognosy and 4Department of Pharmacology, University Victor Segalen Bordeaux 2, 33076 Bordeaux, France


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 Conclusions
 Funding
 References
 
Abnormal Savda Munziq (ASMq) is a traditional Uighur medicinal herbal preparation, commonly used for the treatment and prevention of cancer. We tested the effects of ethanol extract of ASMq on cultured human hepatoma cells (HepG2) to explore the mechanism of its putative anticancer properties, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide, neutral red and lactate dehydrogenase (LDH) leakage assays, testing the incorporation of 3[H]-leucine and 3[H]-nucleosides into protein, DNA and RNA, and quantifying the formation of malondialdehyde–thiobarbituric acid (MDA) adducts. ASMq ethanol extract significantly inhibited the growth of HepG2 and cell viability, increased the leakage of LDH after 48 h or 72 h treatment, in a concentration- and time-dependent manner (P < 0.05). Cellular protein, DNA and RNA synthesis were inhibited in a concentration- and time-dependent manner (P < 0.05). No significant MDA release in culture medium and no lipid peroxidation in cells were observed. The results suggest that the cytotoxic effects of ASMq ethanol extract might be related to inhibition of cancer cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis.

Keywords: Abnormal Savda Munziq – cancer – cytotoxicity – herbal preparation – human hepatoma cells – traditional Uighur medicine


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 Conclusions
 Funding
 References
 
The therapeutic utilization of plants is part of universal human culture, and products derived from plants are frequently used for the treatment or prevention of diseases. Plants, vegetables, herbs and spices used in folk and traditional medicine are one of the sources of cancer drug discovery and development (1). A major group of these products include pigments, vitamins, phenolic lactones, flavonoids, tannins and alkaloids (2,3). Although the mechanism underlying their anticancer effects is often still unclear, the fact that the consumption of fruits, vegetables and some traditional herbal preparations could lower the incidence of carcinogenesis at a wide variety of sites is broadly supported (4,5). The vinca alkaloids and taxane diterpenes are examples of successful plant-derived anticancer agents (6). In the last few years, several other herbal products capable of anticancer effects have been identified, the anticancer properties of which are related to the regulation of cancer-related gene express, induction of apoptosis, cell cycle arrest and/or DNA fragmentation as well as inhibition of different cellular enzymes (7–11).

Traditional Uighur medicine, one of the main medical system in Central Asia, is based on four humors: fire, air, water and earth, which generate four body fluids: Kan (blood), Belghem (phlegm), Sapra (yellow bile) and Savda (black bile). Unbalanced body fluids will cause diseases, and traditional Uighur formulations will regulate the balance of body fluids and cure the disease (12). Abnormal Savda Munziq (ASMq), a herbal formulation of traditional Uighur medicine, is widely used in the Xinjiang region of China, and especially for the treatment and prevention of cancer, diabetes, cardiovascular disorders as well as chronic asthma. Its anticancer properties are usually applied by Uighur physicians to the treatment and prevention of digestive cancers. For liver, stomach and colon cancers, the recommended dose is 500 ml three times a day. The putative mechanism of the anticancer effect is still unclear and needs further investigation. In a previous study, we found that ASMq aqueous extract had scavenging effects to various reactive oxygen species (ROS), and could protect against OH-induced mitochondrial and DNA oxidative damage in vitro (13–16).

In this article, we carried out experimental studies on ASMq ethanol extract on cultured HepG2 cells to elucidate the initial molecular mechanisms responsible for its anticancer effects.


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 Conclusions
 Funding
 References
 
Chemicals Reagents

Dulbecco's modified Eagle medium (DMEM), fetal calf serum (FCS), ethylene diamine tetra-acetic acid (EDTA), phosphate-buffered saline (PBS), N-lauroyl sarcosine (N-LS), ribonuclease A (RNase A), proteinase K, ethidium bromide, trypsine–0.02% EDTA mixture were from Sigma-Aldrich (Lyon, France). 3[H]-leucine, 3[H]-thymidine and 3[H]-uridine were from Perkin Elmer Life Sciences Inc. (Boston, MA, USA). All other chemicals used were of analytical grade.

Preparation of Ethanol Extract of ASMq

ASMq consists of powdered material of the 10 plants described in Table 1 (17). The formulation is prepared according to a proprietary preparation (18). A voucher of each plant is stored in the herbarium of Xinjiang Institute of Ecology and Geography, Chinese Academy of Science. Plant materials were purchased from Xinjiang Hospital of Traditional Uighur Medicine.


View this table:
[in this window]
[in a new window]

  		Table 1. Plants contained in Uighur herbal formula: ASMq

 
Powdered material (7.8 kg) was macerated in ethanol 95% [1:10 (w/v)] at room temperature for 4 h with continuous stirring. The maceration was repeated three times (4 h). After evaporation, the residue was extracted by petroleum ether. The remaining water fraction was concentrated to dryness under reduced pressure and low temperature on a rotary evaporator. Extract yield of plant material was 935 g (12%) (w/w). Extract was dissolved in distilled water (100 mg ml–1) and kept at –20°C prior to utilization. The other concentrations used in the experiment were prepared by addition of cell culture medium (DMEM).

Cell Lines and Culture Medium

Human hepatoma adherent cell lines (HepG2) were obtained from the American Type Culture Collection (ATCC). Cells were cultured and maintained with DMEM supplemented with 10% FCS, 2% L-glutamine (200 mM) and 1% penicillin–streptomycin (100U to 100 mg ml–1) in a humidified 5% CO2–95% air mixture at 37°C.

MTT Assay

Cell viability was determined using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Cells were seeded in 96-well microplates (5000 cells/well/200 ml) and routinely cultured in a humidified incubator for 24 h. Cell culture mediums were removed with a pipette and herbal extracts were added in serial concentrations (ranging from 0.05 to 10 mg ml–1) and re-incubated for 72 h. We also tested a control group (DMEM without herbal extract), a blank group (without cells or medium). The medium with or without herbal extract was then discarded, and 100 ml of MTT solution (0.5 mg ml–1 in DMEM) was added to every well and re-incubated for an additional 2 h. One hundred microliters of 10% SDS, 0.01 M HCl solution was added to each well to dissolve the formazon crystals formed. The plates were then read on a microplate reader (DYNATECH MR 4000, France) at 560 nm. In this test, four wells were used for each concentration of ASMq, and five independent experiments were performed.

Neutral Red Uptake Assay

Cells were seeded in 96-well microplates (10 000 cells/well/200 ml), routinely cultured in a humidified incubator for 24 h. Cells were maintained in culture and exposed to ASMq ethanol extract over a range of concentrations (0.5–7.5 mg ml–1). After 48 h exposure to ASMq, neutral red (NR) uptake test was performed according to the procedure described by Creppy (19). Briefly, at the end of the treatment, the medium with or without ASMq was discarded and 200 µl of freshly prepared neutral red solution (50 µg ml–1) was added to every well and re-incubated for an additional 4 h at 37°C. Thereafter, the cells were carefully washed twice with 200 µl of PBS to eliminate extracellular NR. The incorporated dye was eluted from the cells by adding 200 µl elution medium (50% ethanol supplemented with 1% acetic acid, v/v) into each well followed by gentle shaking of microplate for 15 min. The plates were then read at 540 nm using a microplate reader (DYNATECH MR 4000, France). The number of cells in the presence of ASMq was compared to that observed in control cultures and the percentage of viable cells calculated. The IC50 is determined and expressed as microgram per milliliter.

Lactate Dehydrogenase Leakage Assay

HepG2 cells (1 x 105 cells ml–1well–1) were pre-incubated in 24-well multidishes for 24 h at 5% CO2–95% air 37°C. Cell viability was assessed by lactate dehydrogenase (LDH) leakage trough the membrane into the medium. Aliquots of the cell culture supernatants from control and serial concentration of ASMq ethanol extract treated cultures were tested after 48 or 72 h incubation for the presence of LDH using a LDH assay kit (Biomerieux, France). In this test, three wells were used for each concentration of ASMq, and three independent experiments were performed.

Cellular Protein, DNA and RNA Synthesis Assay

HepG2 cells (2.5 x 105 cells/ml/well) were cultured in 24-well multidishes for 48 h at 37°C. Five concentrations ranging from 0.5 to 7.5 mg ml–1 of extract were used. The control cultures were prepared by adding DMEM without any addition. Four wells were used for each concentration, and two independent experiments were performed. After 24 or 48 h incubation at 37°C with or without extract, the medium removed and 2 mCi ml–1 of a radioactive protein synthesis precursor, 3[H]-leucine (specific activity, 185 GBq mmol–1) or 2 mCi ml–1 of radioactive DNA synthesis precursor, 3[H]-thymidine (specific activity, 3259.76 GBq mmol–1) or 2 mCi ml–1 of radioactive RNA synthesis precursor, 3[H]-uridine (specific activity, 888 GBq mmol–1) was incorporated during a 2.5 h pulse. Once the pulse was finished, the medium was removed and cells were harvested by trypsinization. After centrifuged at 600g for 5 min at 10°C, the supernatants were removed and cell pellets were resuspended by adding 300 ml of 20% NaOH and sonicated for 30 s with Bioblock sonicater at 75 mV, and all the samples were incubated for 20 min at 37°C. Twenty microliters of each homogenate was taken for total protein quantification using the Bradford method (20). The samples were kept in –20°C freezer after addition of 1 ml of cold TCA (40%) until filtration. Lastly, the samples were filtered on 3 mm Whatman microfiber filter discs, which were dried at 80°C for 20 min. The radioactivity on the paper filters was counted with liquid scintillation analyzer after addition of 5 ml of Beckman Ready Organic supplemented by 0.9% acetic acid. The c.p.m. values were adjusted with total protein content in each sample. In this test, four wells were used for each concentration of ASMq ethanol extract, and three independent experiments were performed.

Extraction and Determination of Malondialdehyde–Thiobarbituric Acid Adduct

HepG2 (1 x 105 cells/well/ml) were cultured in 24-well multidishes for 24 h at 37°C. Five concentrations ranging from 0.5 to 7.5 mg ml–1 of ASMq were used. The control cultures were prepared by adding DMEM without any addition. After incubation with or without extract, the culture medium was removed. After rinsing with 0.5 ml of fresh-cold PBS twice, cells were collected by trypsinization, centrifuged at 600g for 5 min. The cell pellets were resuspended in 270 µl of STE (0.1 M NaCl, 20 mM EDTA, 50 mM Tris–HCl, pH 8.0), after adding 25 µl of 7% SDS the cells were sonicated for 30s at 75 mV, 20 ml of each homogenate was taken for total protein quantification (20). The cells were lysed with 20 µl of SDS 7% (w/v), 300 µl of 0.1 M HCl, 40 µl of phosphotungstic acid 1% (w/v) and 300 µl of 0.67% (w/v) thiobarbituric acid. The tubes were shaken for 1 min and incubated at 80°C for 1 h in the dark. They were further placed for 20 min in an ice bath (0°C). After this period, 300 µl of n-butanol was added and tubes were shaken vigorously for 1 min. After centrifugation for 10 min at 900g at 4°C, the n-butanol phase from each sample containing MDA–TBA adduct was separated and analyzed by high performance liquid chromatography (HPLC) with fluorometric detection (21).

The HPLC system consisted of a chromatography pump (Bischoff Chromatography, Germany) equipped with a Shimadzu 8450 Fluorescence HPLC Monitor (Japan Spectroscopic Co.). Analysis of the malondialdehyde–thiobarbituric (MDA–TBA) adducts was performed at room temperature on a Ultrasep C18 column using methanol–water 40:60 (v/v) as the mobile phase adjusted to pH 8.3 by addition of 1 M KOH. The flow rate was maintained at 0.5 ml/min. The excitation and emission wavelengths were 515 and 553 nm, respectively. The amount of MDA–TBA measured was referred to the protein content of cellular homogenates using the Bradford method (20). In this test, three wells were used for each concentration of ASMq, and two independent experiments were performed. Pic3 software was used for the analysis of chromatography.

Statistical Analysis

The data are expressed as mean ± SD of at least three independent determinations in triplicate or quadruplicate for each experimental point. The statistical differences between treated groups and control groups were determined by Student's t-test, and the significance threshold was set to P < 0.05.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 Conclusions
 Funding
 References
 
Inhibition of HepG2 Cell Growth by ASMq Ethanol Extract

After 72 h incubation, ASMq ethanol extract inhibited HepG2 cell growth in a concentration-dependent manner (Fig. 1). ASMq ethanol extract reached its maximum inhibitory effect (68.4%) at 2.5 mg ml–1 (Fig. 1). The IC50 was determined to be 0.8 ± 0.12 mg ml–1.


Figure 1
View larger version (7K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 1. Inhibition of HepG2 cell growth by ASMq ethanol extract. Cells were treated with different concentration of ASMq ethanol extract (0.05–10 mg ml–1) at 37°C, 5% CO2 for 72 h. Cell growth was determined by the MTT assay. Results are expressed as mean ± SD of five independent experiments.

 
Inhibition of HepG2 Cell Viability by ASMq Ethanol Extract

ASMq ethanol extract significantly inhibited HepG2 cell viability in a concentration-dependent manner after 48 h incubation. IC50 was 0.9 ± 0.2 mg ml–1 (Fig. 2).


Figure 2
View larger version (7K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 2. HepG2 cell viability in the presence of increasing concentrations of ASMq ethanol extract. Cells were incubated with different concentrations of ASMq aqueous extract (0.5–7.5 mg ml–1) at 37°C, 5%CO2 for 48 h. Cell viability was determined by the neutral red test. Results are expressed as the mean ± SD of three independent experiments.

 
Increase of LDH Leakage by ASMq Ethanol Extract

There was a significant increase of HepG2 cell membrane LDH leakage after incubation with serial concentrations of ASMq ethanol extract (Fig. 3). In agreement with the results of the MTT test and neutral red test, significant toxicity was observed in HepG2 cells with ASMq concentrations from 0.5 to 7.5 mg ml–1 after 48 or 72 h of treatment (P < 0.05). Concentration dependence was observed at both 48 h and 72 h incubation. In addition, ASMq ethanol extract showed a time-dependent toxicity in our experimental condition with effects greater at 72 h than at 48 h (Fig. 3).


Figure 3
View larger version (12K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 3. Percentage of LDH leakage into the cell culture medium after incubation of HepG2 cells with ASMq ethanol extract. Results are expressed as mean ± SD of three independent experiments. aP < 0.05 compared with control cultures; bP < 0.05 compared with 48 h incubation.

 
Inhibition of Cellular Synthesis of Protein, DNA and RNA by ASMq Ethanol Extract

There was a concentration-dependent inhibition of protein synthesis after 24 h incubation. After 48 h, the inhibition no longer was dose-dependent over the range of doses tested, but seemed stable around 43–52%. Inhibition was significantly greater at 48 than at 24 h for all concentrations (P < 0.05) (Fig. 4).


Figure 4
View larger version (15K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 4. Inhibition of protein synthesis in HepG2 cells after incubation with ASMq ethanol extract. Protein synthesis was evaluated by incorporation of 3[H]-leucine during a 2.5 h pulse. Results are expressed as the mean ± SD of three independent experiments. aP < 0.05 compared with control culture; bP < 0.05, 48 h versus 24 h treatment with ASMq ethanol extract.

 
Increasing concentrations of ASMq ethanol extract from 0.5 to 7.5 mg/ml dose-dependently inhibited cellular DNA synthesis from 8.3 to 35.4% at 24 h, from 15.5% to 48.5% at 48 h (Fig. 5). Inhibition was greater after 48 h than after 24 h incubation.


Figure 5
View larger version (15K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 5. Inhibition of DNA synthesis in HepG2 cells after incubation with ASMq ethanol extract. DNA synthesis was evaluated by incorporation of 3[H]-thymidine during a 2.5 h pulse. Results are expressed as the mean ± SD of three independent experiments. aP < 0.05 compared with control culture; bP < 0.05, 48 h versus 24 h treatment with ASMq.

 
Synthesis of RNA in HepG2 cells was inhibited in a concentration-dependent manner from 14.7% to 46.4% and 26.0% to 55.7% at 24 h and 48 h, respectively (Fig. 6). There was no clear time-dependent increase in this inhibition.


Figure 6
View larger version (15K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 6. Inhibition of RNA synthesis in HepG2 cells after incubation with ASMq ethanol extract. RNA synthesis was evaluated by incorporation of 3[H]-uridine during a 2.5 h pulse. Results were expressed as the mean ± SD from three independent experiments. aP < 0.05, compared with control culture; bP < 0.05 compared with 24 h treatment of ASMq.

 
Lipid Peroxidation of HepG2 Cells by ASMq Ethanol Extract

There was no significant MDA release in culture medium and no lipid peroxidation compared to controls, even at the highest concentration (10, 20 or 50 mg ml–1) (data not shown). This result is in accordance with a previous study showing ASMq had scavenging effects on reactive oxygen species (14).


   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
Conclusions
 Funding
 References
 
ASMq, used for the treatment and prevention of cancers, is made from several plants (Table 1). Pharmacological information that can be related to cancer inhibiting effects of some of the plants is outlined in Table 2.


View this table:
[in this window]
[in a new window]

  		Table 2 Pharmacological activities of plants from Uighur formula: ASMq

 
Various antioxidative activities involving detoxification such as superoxide anion radical scavenging, inhibition of hydrogen peroxide, enhancement of superoxide dismutase, catalase and glutathion peroxidase as well as iron-chelating activities have been reported for several plants extracts such as Anchusa italica, Foeniculum vulgare, Glycyrrhiza sp., Lavandula angustifolia and Melissa officinalis.

Anti-inflammatory activity has been demonstrated using chemical-induced writhing test and carrageenan paw edema for polyphenolic extract and essential oil of L. angustifolia (43). It is thought that these antioxidant and anti-inflammatory properties are related to the treatment of cancer.

Findings on licorice have shown in vitro and in vivo anticancer effects (50,28). Glycyrrhetinic acid, constituent of G. glabra and G. uralensis, developed anti-initiating and anti-promoting activities (39). Isoliquiritigenin, one of the flavonoids of G. glabra, induced apoptosis of MGC-803 cells through calcium and Deltapsi-dependent pathways (36) as well as cell cycle arrest and cell growth inhibition (32). Isoliquiritigenin also activated macrophages and cytotoxicity of splenic lymphocytes (33). Glabrene showed an estrogen receptor-dependent affinity higher than glabridin with growth-promoting effect at low concentration and ER-independent antiproliferative activity at concentrations above 15 mM (37). Licochalcone-A, phytoestrogen from G. glabra, decreased the anti-apoptotic protein bcl-2 and modified the bcl2-/bax ratio in favor of apoptosis (38). Beta-hydroxy-DHP from G. Glabra extract induced Bcl-2 phosphorylation, G2/M cell cycle arrest and apoptosis in breast and prostate tumor cells (34). Recently, the ethanol extract of G. uralensis root has been shown to possess anticancer activity through upregulation of tumor suppressor gene p53, pro-apoptotic protein Bax and p21waf1/cip1 and downregulation of cdk 2 and cyclin E. The extract also caused G1 cell cycle arrest (31). The antiangiogenic activity of G. glabra is also a potential supplemental source to eradicate tumor growth (28).

Other plants have shown interesting results that can suggest their potential uses as antitumoral agents. Essential oils from L. angustifolia showed strong antimutagenic activity in Salmonella typhimurium strains exposed to the direct mutagen 2-nitrofluorene (41). Lavender oil and linalool have also been demonstrated to be cytotoxic to human skin cells in vitro (42). Oil from M. officinalis induced cytotoxicity on human cancer lines (A549, MCF-7, Caco-2, HL-60, K562) and a mouse cell line B16F10 (49).

Though the herbal remedy tested here has been used extensively in traditional Uighur medicine, its effects on cancer cell growth or metabolism had not been tested previously.

In the present study, we used human hepatoma cells (HepG2) to examine the cytotoxic effects of ASMq ethanol extract to elucidate the initial molecular mechanisms responsible for these effects. We demonstrated that ASMq ethanol extract had significant cytotoxic effect by reducing the cell growth rate and cell viability, increasing the extra-cellular LDH leakage and inhibiting cellular protein, DNA and RNA synthesis.

Inhibiting cancer cell growth has been a continuous effort in cancer treatment. Most anticancer agents act by reducing cell growth and inducing cell death through more or less detailed and complicated pathways. Our results showed that ASMq ethanol extract inhibits HepG2 cell growth in a concentration-dependent manner after 72 h incubation. Even at a low concentration, there still was a potent inhibitor effect, the 50% inhibition concentration being determined to be about 0.8 mg ml–1 in our experimental conditions. This result was confirmed by the neutral red test showing that ASMq ethanol extract decreased HepG2 cell viability in a concentration-dependent manner after 48 h incubation.

The most frequently used endpoints in cytotoxicity are the breakdown of the cellular permeability barrier, measured by dye exclusion (trypan blue) or by the release of intracellular enzymes like LDH as a consequence of membrane damage or cell detachment (51). It is well known that cellular injury may lead to a complex sequence of changes to structural and molecular events, frequently culminating in cell death. Many subcellular structures, such as the plasma membrane, nucleus, mitochondria, endoplasmic reticulum and lysosomes are all targets for anticancer agents (52). The LDH leakage assay is based on the principle that dead cells lose the ability to maintain their plasma membrane integrity, permitting intracellular constituents such as LDH to leak out of the cell into the culture medium. ASMq ethanol extract induced a significant increase in extra-cellular LDH levels at both 48 h and 72 h, in a concentration-dependent manner. ASMq ethanol extract also exhibited time-dependent properties on LDH leakage since the effects at 72 h were greater than at 48 h. ASMq ethanol extract may alter the integrity of HepG2 cell plasma membranes either directly or as a secondary result of damage to some other cell component and alter the net rates of nutrient uptake in the cells. Therefore, the cytotoxic effects of ASMq ethanol extract might at least in part be correlated with loss of cell plasma membrane integrity and potential.

Lipid peroxidation is one of the consequences of oxidative damage and has been suggested as a general mechanism for cell injury and death. MDA, the end product of lipid peroxidation, has been extensively studied and measured as an index of lipid peroxidation and as a marker of oxidative stress (53). Many anticancer agents causing cell death are known to induce an overproduction of ROS, and thereby causing oxidative damage to DNA, proteins and lipids and possibly inducing apoptosis. But in our experimental conditions ASMq did not induce significant lipid peroxidation in HepG2 cells after 24 or 48 h. This indicates that probably the mechanism leading to loss of cell membrane integrity is not due to ROS, but more probably to inhibition of lipoproteins in membrane since as shown above ASMq inhibited protein synthesis.

To explore its effect on cell mechanisms, the effects of ASMq ethanol extract on some basic cell functions such as protein, DNA and RNA synthesis were studied showing a concentration and time-dependent inhibition of DNA and protein synthesis in cells treated with ASMq ethanol extract as reflected by its inhibition of 3H-thymidine and 3H-leucine uptake. Our results showed that ASMq ethanol extract obviously decreased DNA and protein synthesis at 24 and 48 h incubation. For DNA synthesis, the inhibition was concentration-dependent after 24 and 48 h incubation, with also a time-dependent effect, the inhibition being greater at 48 than at 24 h for all concentrations, whereas for protein synthesis the inhibition was maximal from the first concentration at 48 h. We found dose dependence for RNA synthesis, but no clear time dependence: there was no difference in the inhibition after 24 or 48 h incubation. DNA, RNA and protein synthesis are directly proportional to cellular growth rate (54,55). Our results likely support this viewpoint: the inhibition of cell growth by ASMq ethanol extract seems closely related to cellular DNA, RNA and protein synthesis inhibition. Thus, inhibition of cellular DNA, RNA and protein synthesis might be involved in the mechanisms of ASMq ethanol extract cytotoxicity effect.


   Conclusions
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
Funding
 References
 
HepG2 cell growth was concentration dependently inhibited by ASMq ethanol extract. Our findings suggest that the cytotoxic effect of ASMq ethanol extract is a combination of its effects in reduction of HepG2 cell growth, alteration of cell membrane integrity and inhibition of cellular protein, DNA and RNA synthesis. As an herbal preparation, ASMq ethanol extract undoubtedly contains a variety of active compounds such as alkaloids, polyphenols or terpenoids, as well as vitamins and fatty acids, which may act on different pathways of cancer cell growth. Further studies will be needed to identify the active compound(s) that confer anticancer activities to ASMq ethanol extract. Once such compounds are identified, the mechanisms by which they exert their effects can begin to be characterized.


   Funding
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Funding
References
 
National Natural Science Foundation of China (30260128); State Administration of Traditional Chinese Medicine of China (2005LHR21).


  Footnotes
 
For reprints and all correspondence: Dr Abdiryim Yusup, Faculty of Traditional Uighur Medicine, Xinjiang Medical University, 393 Xinyi Road, 830011 Urumqi, Xinjiang, China. Tel/Fax: +86-991-43-66-014; E-mail: abdiryim{at}hotmail.com


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusions
 Funding
 References
 

  1. Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev ( 2004;) 28:: 426–32.[CrossRef][Web of Science][Medline]
  2. da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol ( 2001;) 1:: 364–9.[CrossRef][Medline]
  3. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci ( 2005;) 78:: 431–41.[CrossRef][Web of Science][Medline]
  4. Cassileth BR. Alternative and complementary cancer treatments. Oncologist ( 1996;) 1:: 173–9.[Abstract/Free Full Text]
  5. De Smet PA. Herbal remedies. N Engl J Med ( 2002;) 347:: 2046–56.[Free Full Text]
  6. Pinn G. Herbal medicine in oncology. Aust Fam Physician ( 2001;) 30:: 575–80.[Medline]
  7. Lee SM, Li ML, Tse YC, Leung SC, Lee MM, Tsui SK, et al. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci ( 2002;) 71:: 2267–77.[CrossRef][Web of Science][Medline]
  8. Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK. Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol ( 2000;) 58:: 1287–93.[Web of Science][Medline]
  9. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res ( 2002;) 8:: 893–903.[Abstract/Free Full Text]
  10. Wu J, Wu Y, Yang BB. Anticancer activity of Hemsleya amabilis extract. Life Sci ( 2002;) 71:: 2161–70.[CrossRef][Web of Science][Medline]
  11. Huang ST, Yang RC, Yang LJ, Lee PN, Pang JH. Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells. Life Sci ( 2003;) 72:: 1705–16.[CrossRef][Web of Science][Medline]
  12. Upur H, Yusup A, Umar A, Moore N. Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. Therapie ( 2004;) 59:: 483–4.[Web of Science][Medline]
  13. Abuduaini A, Yusup A, Upur H. Studies on the protective effects of Munziq and Mushil of Abnormal Savda to OH-induced DNA damage. Zhongyao Yaoli yu Linchuang Zazhi ( 2000;) 16:: 34–6.
  14. Upur H, Yusup A. Antioxidative effects of Munziq and Mushil. Zhongguo Minzu Yiyao Zazhi ( 2000;) 6:: 30–2.
  15. Yusup A, Upur H, Abuduaini A. ESR studies on the antioxidant effects of Munziq and Mushil of Abnormal Savda. Zhong Yao Xin Yao Yu Lin Chuang Yao Li ( 2001;) 12:: 420–22.
  16. Yusup A, Upur H, Umar A, Moore N. Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage. Fundam Clin Pharmacol ( 2004;) 18:: 471–6.[CrossRef][Web of Science][Medline]
  17. Criteria of Materia Medica, Fascicule of Uighur Medicine. Ministry of Health, People's Republic of China. Science-Technology and Sanitary Press, Urumqi, Xinjiang. 1999.
  18. Upur H, Yusup A. Theory of Hilit and Mizaj on Uighur Medicine and Modern Research on it ( 2003;) Urumqi: Science and Technology Press.
  19. Creppy EE, Chiarappa P, Baudrimont I, Borracci P, Moukha S, Carratu MR. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? Toxicology ( 2004;) 201:: 115–23.[CrossRef][Web of Science][Medline]
  20. Bradford NM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye. Anal Biochem ( 1976;) 72:: 248–254.[CrossRef][Web of Science][Medline]
  21. Abado-Becognee K, Mobio TA, Ennamany R, Fleurat-Lessard F, Shier WT, Badria F, et al. Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein and DNA syntheses. Arch Toxicol ( 1998;) 72:: 233–6.[CrossRef][Web of Science][Medline]
  22. El SN, Karakaya S. Radical scavenging and iron-chelating activities of some greens used as traditional dishes in Mediterranean diet. Int J Food Sci Nutr ( 2004;) 55:: 67–74.[CrossRef][Web of Science][Medline]
  23. Disi AM, Tamimi SO, Abuereish GM. Effects of Anchusa strigosa root aqueous extract on gastric ethanol-induced ulcer in laboratory animals. J Ethnopharmacol ( 1998;) 60:: 189–98.[CrossRef][Web of Science][Medline]
  24. Choi EM, Hwang JK. Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia ( 2004;) 75:: 557–65.[CrossRef][Web of Science][Medline]
  25. Satyanarayana S, Sushruta K, Sarma GS, Srinivas N, Subba Raju GV. Antioxidant activity of the aqueous extracts of spicy food additives—evaluation and comparison with ascorbic acid in in-vitro systems. J Herb Pharmacother ( 2004;) 4:: 1–10.[Medline]
  26. Ruberto G, Baratta MT, Deans SG, Dorman HJ. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med ( 2000;) 66:: 687–93.[CrossRef][Web of Science][Medline]
  27. Guil-Guerrero JL, Diaz Delgado A, Matallana Gonzalez MC, Torija Isasa ME. Fatty acids and carotenes in some ber (Ziziphus jujuba Mill) varieties. Plant Foods Hum Nutr ( 2004;) 59:: 23–7.[CrossRef][Web of Science][Medline]
  28. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol ( 2006;) 6:: 494–8.[CrossRef][Web of Science][Medline]
  29. Jo EH, Kim SH, Ra JC, Kim SR, Cho SD, Jung JW, et al. Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett ( 2005;) 230:: 239–47.[CrossRef][Web of Science][Medline]
  30. Lee SE, Hwang HJ, Ha JS, Jeong HS, Kim JH. Screening of medicinal plant extracts for antioxidant activity. Life Sci ( 2003;) 73:: 167–79.[CrossRef][Web of Science][Medline]
  31. Fukai T, Satoh K, Nomura T, Sakagami H. Antinephritis and radical scavenging activity of prenylflavonoids. Fitoterapia ( 2003;) 74:: 720–4.[CrossRef][Web of Science][Medline]
  32. Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, et al. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol ( 2003;) 43:: 580–6.[CrossRef][Web of Science][Medline]
  33. Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, et al. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett ( 2002;) 183:: 23–30.[CrossRef][Web of Science][Medline]
  34. Rafi MM, Vastano BC, Zhu N, Ho CT, Ghai G, Rosen RT, et al. Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. J Agric Food Chem ( 2002;) 50:: 677–84.[CrossRef][Web of Science][Medline]
  35. Shetty TK, Satav JG, Nair CK. Protection of DNA and microsomal membranes in vitro by Glycyrrhiza glabra L. against gamma irradiation. Phytother Res ( 2002;) 16:: 576–8.[CrossRef][Web of Science][Medline]
  36. Ma J, Fu NY, Pang DB, Wu WY, Xu AL. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med ( 2001;) 67:: 754–7.[Web of Science][Medline]
  37. Tamir S, Eizenberg M, Somjen D, Izrael S, Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol ( 2001;) 78:: 291–8.[CrossRef][Web of Science][Medline]
  38. Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, et al. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res ( 2000;) 20:: 2653–8.[Web of Science][Medline]
  39. Chen XG, Han R. [Effect of glycyrrhetinic acid on DNA damage and unscheduled DNA synthesis induced by benzo (a) pyrene]. Yao Xue Xue Bao ( 1994;) 29:: 725–9.[Medline]
  40. Ferreira A, Proenca C, Serralheiro ML, Araujo ME. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J Ethnopharmacol ( 2006;) 108:: 31–7.[CrossRef][Web of Science][Medline]
  41. Evandri MG, Battinelli L, Daniele C, Mastrangelo S, Bolle P, Mazzanti G. The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay. Food Chem Toxicol ( 2005;) 43:: 1381–7.[CrossRef][Web of Science][Medline]
  42. Prashar A, Locke IC, Evans CS. Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif ( 2004;) 37:: 221–9.[CrossRef][Web of Science][Medline]
  43. Hajhashemi V, Ghannadi A, Sharif B. Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J Ethnopharmacol ( 2003;) 89:: 67–71.[CrossRef][Web of Science][Medline]
  44. Buyukokuroglu ME, Gepdiremen A, Hacimuftuoglu A, Oktay M. The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups. J Ethnopharmacol ( 2003;) 84:: 91–4.[CrossRef][Web of Science][Medline]
  45. Hohmann J, Zupko I, Redei D, Csanyi M, Falkay G, Mathe I, et al. Protective effects of the aerial parts of Salvia officinalis, Melissa Officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med ( 1999;) 65:: 576–8.[Web of Science][Medline]
  46. Proestos C, Chorianopoulos N, Nychas GJ, Komaitis M. RP-HPLC analysis of the phenolic compounds of plant extracts. Investigation of their antioxidant capacity and antimicrobial activity. J Agric Food Chem ( 2005;) 53:: 1190–5.[CrossRef][Web of Science][Medline]
  47. Kadifkova Panovska T, Kulevanova S, Stefova M. In vitro antioxidant activity of some Teucrium species (Lamiaceae). Acta Pharm ( 2005;) 55:: 207–14.[Medline]
  48. Ivanova D, Gerova D, Chervenkov T, Yankova T. Polyphenols and antioxidant capacity of Bulgarian medicinal plants. J Ethnopharmacol ( 2005;) 96:: 145–50.[CrossRef][Web of Science][Medline]
  49. de Sousa AC, Alviano DS, Blank AF, Alves PB, Alviano CS, Gattass CR. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol ( 2004;) 56:: 677–81.[CrossRef][Web of Science][Medline]
  50. Baba M, Asano R, Takigami I, Takahashi T, Ohmura M, Okada Y, et al. Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull ( 2002;) 25:: 247–50.[CrossRef][Web of Science][Medline]
  51. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods ( 1988;) 115:: 61–9.[CrossRef][Web of Science][Medline]
  52. Boobis AR. Cell injury and death. Mechanisms of cell injury. In: Oxford Textbook of Pathology —McGee JD, Isaacson P.G., Wright N.A, eds. ( 1992;) New York, Oxford, 1992, Vol. 1, 181–193.
  53. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol ( 2004;) 142:: 231–55.[CrossRef][Web of Science][Medline]
  54. Valentin I, Philippe M, Lhuguenot J, Chagnon M. Uridine uptake inhibition as a cytotoxicity test for a human hepatoma cell line (HepG2 cells): comparison with the neutral red assay. Toxicology ( 2001;) 158:: 127–39.[CrossRef][Web of Science][Medline]
  55. Yusup A, Upur H, Baudrimont I, Umar A, Kader T, Begaud B, et al. Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. Fundam Clin Pharmacol ( 2005;) 19:: 465–72.[CrossRef][Web of Science][Medline]
Received June 20, 2008; accepted September 11, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Upur, H.
Right arrow Articles by Moore, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Upur, H.
Right arrow Articles by Moore, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?